Log in to save to my catalogue

Early downregulation of hsa-miR-144-3p in serum from drug-naïve Parkinson’s disease patients

Early downregulation of hsa-miR-144-3p in serum from drug-naïve Parkinson’s disease patients

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_82903a0acbcd4727b21688b985baad99

Early downregulation of hsa-miR-144-3p in serum from drug-naïve Parkinson’s disease patients

About this item

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Advanced age represents one of the major risk factors for Parkinson’s Disease. Recent biomedical studies posit a role for microRNAs, also known to be remodelled during ageing. However, the relationship between microRNA remodelling and ageing in Parkinson’s Disease, has not been fully elucidated. Therefore, the aim of the present study is to unravel...

Alternative Titles

Full title

Early downregulation of hsa-miR-144-3p in serum from drug-naïve Parkinson’s disease patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_82903a0acbcd4727b21688b985baad99

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_82903a0acbcd4727b21688b985baad99

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-022-05227-6

How to access this item